In this case, because the sale of dietetic pet food is not a key input to veterinary
clinics, but is rather ancillary to the provision of veterinary services, the Commission considers that Mars would be unlikely to successfully divert customers away from AniCura’s downstream rivals, by restricting its supply of dietetic pet food to them. Rather, the Commission is of the view that Mars would face a greater risk of losing dietetic pet food sales, if it attempted an input foreclosure strategy regarding the supply of dietetic pet food. For these reasons, the Commission considers that Mars has the incentive to sell its dietetic pet food in as many retail outlets as possible.